Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma

被引:70
|
作者
Wright, Abigail [1 ]
Wijeratne, Aruni [1 ]
Hung, Tracy [1 ]
Gao, Wei [2 ]
Whittaker, Sean [1 ,2 ]
Morris, Steven [1 ]
Scarisbrick, Julia [1 ]
Beynon, Teresa [1 ]
机构
[1] St Thomas Hosp, London SE1 7EH, England
[2] Kings Coll London, Kings Hlth Partners, London WC2R 2LS, England
关键词
Pruritus; itch; cutaneous T-cell lymphoma; CTCL; Skindex-29; quality of life; palliative care; MYCOSIS-FUNGOIDES; INTERNATIONAL-SOCIETY; PROGNOSTIC-FACTORS; SEZARY-SYNDROME; ORGANIZATION; SURVIVAL; PROPOSAL; OUTCOMES;
D O I
10.1016/j.jpainsymman.2012.01.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom burden. Pruritus appears to be one of the most prominent and disturbing symptoms. Objectives. To describe the prevalence and severity of pruritus and quality of life (QOL) in patients with CTCL. Methods. Patients with CTCL able to complete two questionnaires were invited to complete a visual analogue scale for itch (VAS(itch)) and the Skindex-29. Prevalence of pruritus, mean score, and SD were estimated for the VAS(itch) and Skindex-29, and the Pearson's correlation coefficient was calculated to evaluate the relationship between severity of pruritus and QOL. Results. One hundred patients were recruited (mean [SD] age 57.9 [12.9] years, range 30-86 years). Eighty-eight percent reported pruritus in the preceding four weeks, 46% indicating that it was often or always a problem. The mean (SD) of VAS(itch) (n = 92) was 3.2 (3.2), range zero to 10. The mean (SD) total Skindex-29 score was 43.3 (27.7). More advanced disease stage was associated with poorer QOL. The Skindex-29 correlated strongly with the VAS(itch) (Pearson's correlation coefficient = 0.72, P < 0.001). Conclusion. All aspects of QOL are affected in CTCL. Pruritus is a common and troublesome symptom. A more advanced disease stage and more severe pruritus symptoms were associated with poorer QOL in this study. J Pain Symptom Manage 2013;45:114-119. (C) 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [21] Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients
    Ottevanger, Rosanne
    van Beugen, Sylvia
    Kersten, Juliette M.
    Evers, Andrea W. M.
    Vermeer, Maarten H.
    Willemze, Rein
    Quint, Koen D.
    CANCERS, 2024, 16 (05)
  • [22] Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma
    Demierre, MF
    Tien, A
    Miller, D
    ARCHIVES OF DERMATOLOGY, 2005, 141 (03) : 325 - 330
  • [24] PRURITUS IN CUTANEOUS T-CELL LYMPHOMAS
    Meyer, Nicolas
    Paul, Carle
    Viraben, Roland
    Misery, Laurent
    ACTA DERMATO-VENEREOLOGICA, 2011, 91 (05) : 617 - 617
  • [25] Relief of intractable pruritus with romidepsin in patients with cutaneous T-cell lymphoma: A series of four cases
    Poligone, Brian
    Rubio-Gonzalez, Belen
    Querfeld, Christiane
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [26] Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma
    Demierre, MF
    Kim, YH
    Zackheim, HS
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) : 1485 - +
  • [27] Global response score correlates with quality of life in cutaneous T-cell lymphoma
    Khan, Niloufer
    Drill, Esther
    Moskowitz, Alison
    Shinohara, Michi
    Larocca, Cecelia
    Querfeld, Christiane
    Zain, Jasmine
    Horwitz, Steven
    QUALITY OF LIFE RESEARCH, 2024, 33 : S69 - S70
  • [28] Itch as a quality of life indicator in patients with cutaneous T cell lymphoma
    Ottevanger, R.
    Van Beugen, S.
    Evers, A. W. M.
    Willemze, R.
    Vermeer, M. H.
    Quint, K. D.
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : S39 - S39
  • [29] An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma
    Hu, Man
    Scheffel, Joerg
    Elieh-Ali-Komi, Daniel
    Maurer, Marcus
    Hawro, Tomasz
    Metz, Martin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4177 - 4197
  • [30] What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus
    Soares, Georgia Biazus
    Guitart, Joan
    Yosipovitch, Gil
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (01) : 67 - 77